Saizen Related Published Studies
Well-designed clinical trials possibly related to Saizen (Somatropin)
Growth hormone treatment for growth failure in pediatric patients with Crohn's disease. [2008.11]
Improved growth velocity during thyroid hormone therapy in children with Fanconi anemia and borderline thyroid function. [2008.11]
A randomized controlled crossover trial of the effect of ginseng consumption on the immune response to moderate exercise in healthy sedentary men. [2008.10]
Immune, endocrine, and behavioral precursors to breast cancer recurrence: a case-control analysis. [2008.10]
Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study. [2008.09.17]
Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation. [2008.09.12]
Oxytocin alleviates the neuroendocrine and cytokine response to bacterial endotoxin in healthy men. [2008.09]
Dose-Dependent Effect of Growth Hormone on Final Height in Children with Short Stature without Growth Hormone deficiency. [2008.08.26]
Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial. [2008.08.06]
The Effects of Growth Hormone and/or Testosterone on Whole Body Protein Kinetics and Skeletal Muscle Gene Expression in Healthy Elderly Men: A Randomized Controlled Trial. [2008.08]
Induction of tolerance of dopaminergic responses in man. [2008.08]
Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD). [2008.08]
Serum ghrelin levels in inflammatory bowel disease with relation to disease activity and nutritional status. [2008.08]
Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial. [2008.08]
Somatotropic responses to soy protein alone and as part of a meal. [2008.07]
Recombinant human growth hormone increases albumin and prolongs survival in patients with chronic liver failure: a pilot open, randomized, and controlled clinical trial. [2008.07]
The exon 3-deleted/full-length growth hormone receptor polymorphism does not influence the effect of puberty or growth hormone therapy on glucose homeostasis in short non-growth hormone-deficient small-for-gestational-age children: results from a two-year controlled prospective study. [2008.07]
Treatment of altered body composition in HIV-associated lipodystrophy: comparison of rosiglitazone, pravastatin, and recombinant human growth hormone. [2008.07]
Effects of recombinant bovine somatotropin (rbST) and season on plasma and milk insulin-like growth factors I (IGF-I) and II (IGF-II) in lactating dairy cows. [2008.07]
Pregnancy success of lactating Holstein cows after a single administration of a sustained-release formulation of recombinant bovine somatotropin. [2008.06.26]
Growth Hormone Treatment for Growth Failure in Pediatric Patients with Crohn's Disease. [2008.06.25]
A Randomised Study of Two Doses of Biosynthetic Human Growth Hormone on Final Height of Pubertal Children with Growth Hormone Deficiency. [2008.06.12]
Frequent intravenous pulses of growth hormone together with glutamine supplementation in prolonged critical illness after multiple trauma: effects on nitrogen balance, insulin resistance, and substrate oxidation. [2008.06]
Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study. [2008.06]
Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial. [2008.06]
Pharmacodynamics of growth hormone abuse biomarkers and the influence of gender and testosterone: a randomized double-blind placebo-controlled study in young recreational athletes. [2008.06]
Effects of raloxifene and hormone replacement therapy on serum Th2 and Th3 type cytokine concentrations in healthy postmenopausal women: a randomised controlled trial. [2008.06]
Targeting prostate cancer with HTI-286, a synthetic analog of the marine sponge product hemiasterlin. [2008.05.15]
Lapatinib versus hormone therapy in patients with advanced renal cell carcinoma: a randomized phase III clinical trial. [2008.05.10]
24-hour serum levels of growth hormone, prolactin, and cortisol in pre- and postmenopausal women: the effect of combined estrogen and progestin treatment. [2008.05]
Dose-escalation of filgrastim does not improve efficacy: Clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxel. [2008.05]
Effect of recombinant human TNF-binding protein-1 and GnRH antagonist on mRNA expression of inflammatory cytokines and adhesion and growth factors in endometrium and endometriosis tissues in baboons. [2008.05]
HER2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, information. [2008.05]
Effect of a pre-exercise energy supplement on the acute hormonal response to resistance exercise. [2008.05]
Ghrelin alone or co-administered with GHRH or CRH increases non-REM sleep and decreases REM sleep in young males. [2008.05]
Different responses in postprandial plasma ghrelin and GH levels induced by concentrate or timothy hay feeding in wethers. [2008.05]
Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial. [2008.05]
Weekly paclitaxel in the adjuvant treatment of breast cancer. [2008.04.17]
Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis. [2008.04]
Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients. [2008.04]
Remifentanil for cesarean section under general anesthesia: effects on maternal stress hormone secretion and neonatal well-being: a randomized trial. [2008.04]
Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the Citrudose pharmacokinetic study. [2008.04]
An evidence-based approach to hormonal therapies for premenopausal women with fibroids. [2008.04]
Effects of acute prednisolone administration on exercise endurance and metabolism. [2008.04]
Changes in insulin sensitivity and glucose metabolism during therapy with recombinant human growth hormone in short children born small for gestational age show a negative correlation with baseline measurements. [2008.04]
Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial. [2008.04]
Randomized controlled growth hormone trial: Effects on anthropometry, body composition, and body proportions in a large group of children with Prader-Willi syndrome. [2008.03.18]
Endocrine and ovarian response after a 2-day controlled suckling and eCG treatment in lactating rabbit does. [2008.03.03]
Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial. [2008.03.01]
Combination of recombinant human growth hormone and propranolol decreases hypermetabolism and inflammation in severely burned children. [2008.03]
A single circuit-resistance exercise has no effect on plasma obestatin levels in female college students. [2008.03]
Growth hormone treatment and fat redistribution in children born small for gestational age. [2008.03]
The growth hormone response to repeated bouts of sprint exercise with and without suppression of lipolysis in men. [2008.03]
Pituitary and/or Peripheral Estrogen-Receptor {alpha} Regulates Follicle-Stimulating Hormone Secretion, Whereas Central Estrogenic Pathways Direct Growth Hormone and Prolactin Secretion in Postmenopausal Women. [2008.03]
Gonadal Status and Body Mass Index Jointly Determine Growth Hormone (GH)-Releasing Hormone/GH-Releasing Peptide Synergy in Healthy Men. [2008.03]
Neuroimmunomodulation in medical oncology: application of psychoneuroimmunology with subcutaneous low-dose IL-2 and the pineal hormone melatonin in patients with untreatable metastatic solid tumors. [2008.03]
Prevention of disuse muscular weakness by restriction of blood flow. [2008.03]
In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. [2008.03]
Growth hormone enhances thymic function in HIV-1-infected adults. [2008.03]
Stimulation of both type I and type II corticosteroid receptors blunts counterregulatory responses to subsequent hypoglycemia in healthy man. [2008.03]
Impact of growth hormone and dehydroepiandrosterone on protein metabolism in glucocorticoid-treated patients. [2008.03]
Anastrozole Increases Predicted Adult Height of Short Adolescent Males Treated with Growth Hormone: A Randomized, Placebo-Controlled, Multicenter Trial for One to Three Years. [2008.03]
Ghrelin agonist (TZP-101): safety, pharmacokinetics and pharmacodynamic evaluation in healthy volunteers: a phase I, first-in-human study. [2008.02]
Effects of oral ingestion of amino acids and proteins on the somatotropic axis. [2008.02]
Enhancement of muscle mitochondrial function by growth hormone. [2008.02]
Relationship between GH-induced metabolic changes and changes in body composition: a dose and time course study in GH-deficient adults. [2008.02]
Letrozole versus letrozole plus Lapatinib (GW572016) in hormone-sensitive, HER2-negative operable breast cancer: a double-blind, randomized, phase II study with biomarker evaluation (EGF109077-LAP107692/LETLOB). [2008.02]
A six-month randomized controlled trial of exercise and pyridostigmine in the treatment of fibromyalgia. [2008.02]
An examination of the role of feeding regimens in regulating metabolism during the broiler breeder grower period. 2. Plasma hormones and metabolites. [2008.02]
Cross-transfer effects of resistance training with blood flow restriction. [2008.02]
Frequent intravenous pulses of growth hormone together with alanylglutamine supplementation in prolonged critical illness after multiple trauma: Effects on glucose control, plasma IGF-I and glutamine. [2008.02]
Estro-progestin supplementation enhances the growth hormone secretory responsiveness to ghrelin infusion in postmenopausal women. [2008.02]
Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study. [2008.01.29]
Growth hormone replacement therapy in adults with growth hormone deficiency improves maximal oxygen consumption independently of dosing regimen or physical activity. [2008.01]
Human blood neutrophil responses to prolonged exercise with and without a thermal clamp. [2008.01]
Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome. [2008.01]
Growth hormone isoform responses to GABA ingestion at rest and after exercise. [2008.01]
Effects of acute prednisolone intake on substrate utilization during submaximal exercise. [2008.01]
The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. [2008.01]
Physical effects of short-term recombinant human growth hormone administration in abstinent steroid dependency. [2008]
Concerns, expectations and perception regarding stature, physical appearance and psychosocial functioning before and during high-dose growth hormone treatment of short pre-pubertal children born small for gestational age. [2008]
Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast. [2008]
Long-term effect on body composition and metabolic parameters after treatment with recombinant human growth hormone (r-hGH) in HIV-1 infected patients with lipodystrophy. [2008]
Evaluation of the pituitary function with insulin tolerance (hypoglycaemia) testing: are there any differences using insulin lispro compared to regular insulin? [2008]
A randomised study of the effect of two doses of biosynthetic human growth hormone on final height of children with familial short stature. [2008]
A randomised study of two doses of biosynthetic human growth hormone on final height of pubertal children with growth hormone deficiency. [2008]
Prednisone plus gefitinib versus prednisone plus placebo in the treatment of hormone-refractory prostate cancer: a randomized phase II trial. [2008]
Effects of short-term application of low-dose growth hormone on trace element metabolism and blood glucose in surgical patients. [2007.12.14]
Metabolic effects of a growth hormone-releasing factor in patients with HIV. [2007.12.06]
Effects of an amino acid/creatine energy supplement on the acute hormonal response to resistance exercise. [2007.12]
Effect of protein-rich feeding on recovery after intense exercise. [2007.12]
Overture for growth hormone: requiem for interleukin-6? [2007.12]
Early elective insulin therapy can reduce hyperglycemia and increase insulin-like growth factor-I levels in very low birth weight infants. [2007.12]
Growth hormone as concomitant treatment in severe fibromyalgia associated with low IGF-1 serum levels. A pilot study. [2007.11.30]
Lipolysis and fatty acid metabolism in men and women during the postexercise recovery period. [2007.11.01]
Effects of parenteral nutrition without and with growth hormone on growth hormone/insulin-like growth factor-1 axis after hepatectomy in hepatocellular carcinoma with liver cirrhosis. [2007.11]
Cardiovascular effects of intravenous ghrelin infusion in healthy young men. [2007.11]
Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride. [2007.11]
Effects of a multi-nutrient supplement on exercise performance and hormonal responses to resistance exercise. [2007.11]
Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone. [2007.11]
Reduction in proliferation with six months of letrozole in women on hormone replacement therapy. [2007.11]
|
